**Author details**

Kang-Hoon Lee and Je-Yoel Cho\* Department of Biochemistry, BK21 PLUS Program for Creative Veterinary Science Research and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, South Korea

\*Address all correspondence to: jeycho@snu.ac.kr

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**95**

*Endogenous Retroelements in Cancer: Molecular Roles and Clinical Approach*

America. 2004;**101**(Suppl 2):

[11] Gonzalez-Cao M et al. Human endogenous retroviruses and cancer. Cancer Biology & Medicine.

[12] Bannert N et al. HERVs new role in cancer: From accused perpetrators to cheerful protectors. Frontiers in

[13] Yu HL, Zhao ZK, Zhu F. The role of human endogenous retroviral long terminal repeat sequences in human cancer (review). International Journal of Molecular Medicine.

[14] Pfeifer GP. Defining driver DNA methylation changes in human cancer. International Journal of Molecular

[15] Jansz N. DNA methylation dynamics at transposable elements in mammals. DNA Methylation. 2019;**63**(6):677-689

[16] Bourque G et al. Ten things you should know about transposable elements. Genome Biology. 2018;**19**:199

[17] Palazzo AF, Gregory TR. The case for junk DNA. PLoS Genetics.

[18] Tokuyama M et al. ERVmap analysis reveals genome-wide transcription of human endogenous retroviruses. Proceedings of the National Academy of Sciences of the United States of America. 2018;**115**(50):12565-12572

regulation. Current Opinion in Genetics

& Development. 2016;**37**:90-100

[20] Casacuberta E, Gonzalez J. The impact of transposable elements in

2014;**10**(5):e1004351

[19] Mita P, Boeke JD. How retrotransposons shape genome

14572-14579

2016;**13**(4):483-488

Microbiology. 2018;**9**:178

2013;**32**(4):755-762

Sciences. 2018;**19**(4):1166

*DOI: http://dx.doi.org/10.5772/intechopen.93370*

[1] Collins FS et al. A vision for the future of genomics research. Nature.

[2] Hofker MH, Fu J, Wijmenga C. The genome revolution and its role in understanding complex diseases. Biochimica et Biophysica Acta. 2014;**1842**(10):1889-1895

diversity: Transposable element insertions in genetic variation and disease. Mobile DNA. 2010;**1**(1):21

2009;**10**(10):691-703

[5] Beck CR et al. LINE-1

on mammalian genomes.

MDNA3-0061-2014

2011;**179**(4):1588-1590

2018;**29**(11):2183-2191

[3] O'Donnell KA, Burns KH. Mobilizing

[4] Cordaux R, Batzer MA. The impact of retrotransposons on human genome evolution. Nature Reviews. Genetics.

retrotransposition activity in human genomes. Cell. 2010;**141**(7):1159-1170

[6] Richardson SR et al. The influence of LINE-1 and SINE retrotransposons

Microbiology Spectrum. 2015;**3**(2)

[7] Mason AL, Gilady SY, Mackey JR. Mouse mammary tumor virus in human breast cancer red herring or smoking gun? American Journal of Pathology.

[8] Kassiotis G. Endogenous retroviruses and the development of cancer. Journal of Immunology. 2014;**192**(4):1343-1349

[10] Bannert N, Kurth R. Retroelements

[9] Attermann AS et al. Human endogenous retroviruses and their implication for immunotherapeutics of cancer. Annals of Oncology.

and the human genome: New perspectives on an old relation. Proceedings of the National Academy of Sciences of the United States of

2003;**422**(6934):835-847

**References**

*Endogenous Retroelements in Cancer: Molecular Roles and Clinical Approach DOI: http://dx.doi.org/10.5772/intechopen.93370*

## **References**

*Methods in Molecular Medicine*

**94**

**Author details**

Kang-Hoon Lee and Je-Yoel Cho\*

Medicine, Seoul National University, Seoul, South Korea

\*Address all correspondence to: jeycho@snu.ac.kr

provided the original work is properly cited.

Department of Biochemistry, BK21 PLUS Program for Creative Veterinary Science Research and Research Institute for Veterinary Science, College of Veterinary

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium,

[1] Collins FS et al. A vision for the future of genomics research. Nature. 2003;**422**(6934):835-847

[2] Hofker MH, Fu J, Wijmenga C. The genome revolution and its role in understanding complex diseases. Biochimica et Biophysica Acta. 2014;**1842**(10):1889-1895

[3] O'Donnell KA, Burns KH. Mobilizing diversity: Transposable element insertions in genetic variation and disease. Mobile DNA. 2010;**1**(1):21

[4] Cordaux R, Batzer MA. The impact of retrotransposons on human genome evolution. Nature Reviews. Genetics. 2009;**10**(10):691-703

[5] Beck CR et al. LINE-1 retrotransposition activity in human genomes. Cell. 2010;**141**(7):1159-1170

[6] Richardson SR et al. The influence of LINE-1 and SINE retrotransposons on mammalian genomes. Microbiology Spectrum. 2015;**3**(2) MDNA3-0061-2014

[7] Mason AL, Gilady SY, Mackey JR. Mouse mammary tumor virus in human breast cancer red herring or smoking gun? American Journal of Pathology. 2011;**179**(4):1588-1590

[8] Kassiotis G. Endogenous retroviruses and the development of cancer. Journal of Immunology. 2014;**192**(4):1343-1349

[9] Attermann AS et al. Human endogenous retroviruses and their implication for immunotherapeutics of cancer. Annals of Oncology. 2018;**29**(11):2183-2191

[10] Bannert N, Kurth R. Retroelements and the human genome: New perspectives on an old relation. Proceedings of the National Academy of Sciences of the United States of

America. 2004;**101**(Suppl 2): 14572-14579

[11] Gonzalez-Cao M et al. Human endogenous retroviruses and cancer. Cancer Biology & Medicine. 2016;**13**(4):483-488

[12] Bannert N et al. HERVs new role in cancer: From accused perpetrators to cheerful protectors. Frontiers in Microbiology. 2018;**9**:178

[13] Yu HL, Zhao ZK, Zhu F. The role of human endogenous retroviral long terminal repeat sequences in human cancer (review). International Journal of Molecular Medicine. 2013;**32**(4):755-762

[14] Pfeifer GP. Defining driver DNA methylation changes in human cancer. International Journal of Molecular Sciences. 2018;**19**(4):1166

[15] Jansz N. DNA methylation dynamics at transposable elements in mammals. DNA Methylation. 2019;**63**(6):677-689

[16] Bourque G et al. Ten things you should know about transposable elements. Genome Biology. 2018;**19**:199

[17] Palazzo AF, Gregory TR. The case for junk DNA. PLoS Genetics. 2014;**10**(5):e1004351

[18] Tokuyama M et al. ERVmap analysis reveals genome-wide transcription of human endogenous retroviruses. Proceedings of the National Academy of Sciences of the United States of America. 2018;**115**(50):12565-12572

[19] Mita P, Boeke JD. How retrotransposons shape genome regulation. Current Opinion in Genetics & Development. 2016;**37**:90-100

[20] Casacuberta E, Gonzalez J. The impact of transposable elements in

environmental adaptation. Molecular Ecology. 2013;**22**(6):1503-1517

[21] Miousse IR et al. Response of transposable elements to environmental stressors. Mutation Research, Reviews in Mutation Research. 2015;**765**:19-39

[22] Jung YD et al. Retroelements: Molecular features and implications for disease. Genes & Genetic Systems. 2013;**88**(1):31-43

[23] Tam OH, Ostrow LW, Gale Hammell M. Diseases of the nervous system: Retrotransposon activity in neurodegenerative disease. Mobile DNA. 2019;**10**:32

[24] Szpakowski S et al. Loss of epigenetic silencing in tumors preferentially affects primatespecific retroelements. Gene. 2009;**448**(2):151-167

[25] Walter M et al. An epigenetic switch ensures transposon repression upon dynamic loss of DNA methylation in embryonic stem cells. eLife. 2016;**5**:e11418

[26] Li E, Zhang Y. DNA methylation in mammals. Cold Spring Harbor Perspectives in Biology. 2014;**6**(5):a019133

[27] Law JA, Jacobsen SE. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nature Reviews. Genetics. 2010;**11**(3):204-220

[28] Adalsteinsson BT, Ferguson-Smith AC. Epigenetic control of the genome-lessons from genomic imprinting. Genes (Basel). 2014;**5**(3):635-655

[29] Leung D et al. Regulation of DNA methylation turnover at LTR retrotransposons and imprinted loci by the histone methyltransferase Setdb1. Proceedings of the National Academy

of Sciences of the United States of America. 2014;**111**(18):6690-6695

[30] Jones PA, Liang GN. OPINION rethinking how DNA methylation patterns are maintained. Nature Reviews Genetics. 2009;**10**(11):805-811

[31] Rowe HM, Trono D. Dynamic control of endogenous retroviruses during development. Virology. 2011;**411**(2):273-287

[32] Zeng Y, Chen TP. DNA methylation reprogramming during mammalian development. Genes. 2019;**10**(4):257

[33] Zamudio N et al. DNA methylation restrains transposons from adopting a chromatin signature permissive for meiotic recombination. Genes & Development. 2015;**29**(12):1256-1270

[34] Costello JF, Plass C. Methylation matters. Journal of Medical Genetics. 2001;**38**(5):285-303

[35] Estecio MRH et al. LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS One. 2007;**2**(5):e399

[36] Lavasanifar A et al. Long interspersed nuclear element-1 mobilization as a target in cancer diagnostics, prognostics and therapeutics. Clinica Chimica Acta. 2019;**493**:52-62

[37] Cheung HH et al. DNA methylation of cancer genome. Birth Defects Research Part C-Embryo Today-Reviews. 2009;**87**(4):335-350

[38] Jeong S et al. Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma. BMC Cancer. 2017;**17**:588

[39] Schulz WA et al. Factor interaction analysis for chromosome 8 and DNA

**97**

*Endogenous Retroelements in Cancer: Molecular Roles and Clinical Approach*

breast cancer patients: A retrospective cohort study. Breast Cancer Research and Treatment. 2012;**134**(3):1103-1114

[49] Miousse IR, Koturbash I. The fine LINE: Methylation drawing the cancer landscape. BioMed Research International. 2015;**2015**:131547

[50] Kreimer U et al. HERV-K and LINE-1 DNA methylation and reexpression in urothelial carcinoma. Frontiers in Oncology. 2013;**3**:255

[51] Li M et al. Downregulation of human endogenous retrovirus type K (HERV-K) viral env RNA in pancreatic cancer cells decreases cell proliferation and tumor growth. Clinical Cancer Research. 2017;**23**(19):5892-5911

[52] Molaro A, Malik HS. Hide and seek: How chromatin-based pathways silence retroelements in the mammalian germline. Current Opinion in Genetics

& Development. 2016;**37**:51-58

2016;**59**:118-125

[53] Yang F, Wang PJ. Multiple LINEs of retrotransposon silencing mechanisms in the mammalian germline. Seminars in Cell & Developmental Biology.

[54] Goering W, Ribarska T, Schulz WA. Selective changes of retroelement expression in human prostate cancer. Carcinogenesis. 2011;**32**(10):1484-1492

[55] Sytnikova YA et al. Transposable element dynamics and PIWI regulation impacts lncRNA and gene expression diversity in Drosophila ovarian cell cultures. Genome Research.

[56] Ozata DM et al. PIWI-interacting

functions. Nature Reviews. Genetics.

[57] Lim AK, Tao L, Kai T. piRNAs mediate posttranscriptional

retroelement silencing and localization

2014;**24**(12):1977-1990

2019;**20**(2):89-108

RNAs: Small RNAs with big

*DOI: http://dx.doi.org/10.5772/intechopen.93370*

methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer.

[41] Wang-Johanning F et al. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer. Clinical Cancer Research.

[42] Huang G et al. Human endogenous retroviral K element encodes fusogenic activity in melanoma cells. Journal of

[43] Cherkasova E et al. Detection of an immunogenic HERV-E envelope with selective expression in clear cell kidney cancer. Cancer Research.

[44] Johanning GL et al. Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype. Scientific

[45] Babaian A, Mager DL. Endogenous retroviral promoter exaptation in human cancer. Mobile DNA. 2016;**7**:24

[46] Zhang M, Liang JQ, Zheng S. Expressional activation and functional roles of human endogenous retroviruses in cancers. Reviews in Medical Virology.

[47] Menendez L, Benigno BB, McDonald JF. L1 and HERV-W

retrotransposons are hypomethylated in human ovarian carcinomas. Molecular

Hypomethylation of LINE-1 in primary tumor has poor prognosis in young

Molecular Cancer. 2007;**6**:14

2001;**7**(6):1553-1560

Carcinogenesis. 2013;**12**:5

2016;**76**(8):2177-2185

Reports. 2017;**7**:41960

2019;**29**(2):e2025

Cancer. 2004;**3**:12

[48] van Hoesel AQ et al.

[40] Jorda M et al. The epigenetic landscape of Alu repeats delineates the structural and functional genomic architecture of colon cancer cells. Genome Research. 2017;**27**(1):118-132

*Endogenous Retroelements in Cancer: Molecular Roles and Clinical Approach DOI: http://dx.doi.org/10.5772/intechopen.93370*

methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer. Molecular Cancer. 2007;**6**:14

*Methods in Molecular Medicine*

Ecology. 2013;**22**(6):1503-1517

[21] Miousse IR et al. Response of transposable elements to environmental stressors. Mutation Research, Reviews in Mutation Research. 2015;**765**:19-39

[22] Jung YD et al. Retroelements: Molecular features and implications for disease. Genes & Genetic Systems.

[23] Tam OH, Ostrow LW, Gale Hammell M. Diseases of the nervous system: Retrotransposon activity in neurodegenerative disease. Mobile DNA. 2019;**10**:32

[24] Szpakowski S et al. Loss of epigenetic silencing in tumors preferentially affects primatespecific retroelements. Gene.

[25] Walter M et al. An epigenetic switch ensures transposon

repression upon dynamic loss of DNA methylation in embryonic stem cells.

[26] Li E, Zhang Y. DNA methylation

[27] Law JA, Jacobsen SE. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nature Reviews. Genetics.

2009;**448**(2):151-167

eLife. 2016;**5**:e11418

2014;**6**(5):a019133

2010;**11**(3):204-220

2014;**5**(3):635-655

[28] Adalsteinsson BT,

Ferguson-Smith AC. Epigenetic control of the genome-lessons from genomic imprinting. Genes (Basel).

[29] Leung D et al. Regulation of DNA methylation turnover at LTR retrotransposons and imprinted loci by the histone methyltransferase Setdb1. Proceedings of the National Academy

in mammals. Cold Spring Harbor Perspectives in Biology.

2013;**88**(1):31-43

environmental adaptation. Molecular

of Sciences of the United States of America. 2014;**111**(18):6690-6695

[30] Jones PA, Liang GN. OPINION rethinking how DNA methylation patterns are maintained. Nature Reviews

Genetics. 2009;**10**(11):805-811

2011;**411**(2):273-287

2001;**38**(5):285-303

2007;**2**(5):e399

2019;**493**:52-62

2017;**17**:588

[31] Rowe HM, Trono D. Dynamic control of endogenous retroviruses during development. Virology.

[32] Zeng Y, Chen TP. DNA methylation reprogramming during mammalian development. Genes. 2019;**10**(4):257

[33] Zamudio N et al. DNA methylation restrains transposons from adopting a chromatin signature permissive for meiotic recombination. Genes & Development. 2015;**29**(12):1256-1270

[34] Costello JF, Plass C. Methylation matters. Journal of Medical Genetics.

[35] Estecio MRH et al. LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS One.

[36] Lavasanifar A et al. Long interspersed nuclear element-1 mobilization as a target in cancer diagnostics, prognostics and therapeutics. Clinica Chimica Acta.

[37] Cheung HH et al. DNA methylation

of cancer genome. Birth Defects Research Part C-Embryo Today-Reviews. 2009;**87**(4):335-350

[38] Jeong S et al. Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma. BMC Cancer.

[39] Schulz WA et al. Factor interaction analysis for chromosome 8 and DNA

**96**

[40] Jorda M et al. The epigenetic landscape of Alu repeats delineates the structural and functional genomic architecture of colon cancer cells. Genome Research. 2017;**27**(1):118-132

[41] Wang-Johanning F et al. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer. Clinical Cancer Research. 2001;**7**(6):1553-1560

[42] Huang G et al. Human endogenous retroviral K element encodes fusogenic activity in melanoma cells. Journal of Carcinogenesis. 2013;**12**:5

[43] Cherkasova E et al. Detection of an immunogenic HERV-E envelope with selective expression in clear cell kidney cancer. Cancer Research. 2016;**76**(8):2177-2185

[44] Johanning GL et al. Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype. Scientific Reports. 2017;**7**:41960

[45] Babaian A, Mager DL. Endogenous retroviral promoter exaptation in human cancer. Mobile DNA. 2016;**7**:24

[46] Zhang M, Liang JQ, Zheng S. Expressional activation and functional roles of human endogenous retroviruses in cancers. Reviews in Medical Virology. 2019;**29**(2):e2025

[47] Menendez L, Benigno BB, McDonald JF. L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas. Molecular Cancer. 2004;**3**:12

[48] van Hoesel AQ et al. Hypomethylation of LINE-1 in primary tumor has poor prognosis in young

breast cancer patients: A retrospective cohort study. Breast Cancer Research and Treatment. 2012;**134**(3):1103-1114

[49] Miousse IR, Koturbash I. The fine LINE: Methylation drawing the cancer landscape. BioMed Research International. 2015;**2015**:131547

[50] Kreimer U et al. HERV-K and LINE-1 DNA methylation and reexpression in urothelial carcinoma. Frontiers in Oncology. 2013;**3**:255

[51] Li M et al. Downregulation of human endogenous retrovirus type K (HERV-K) viral env RNA in pancreatic cancer cells decreases cell proliferation and tumor growth. Clinical Cancer Research. 2017;**23**(19):5892-5911

[52] Molaro A, Malik HS. Hide and seek: How chromatin-based pathways silence retroelements in the mammalian germline. Current Opinion in Genetics & Development. 2016;**37**:51-58

[53] Yang F, Wang PJ. Multiple LINEs of retrotransposon silencing mechanisms in the mammalian germline. Seminars in Cell & Developmental Biology. 2016;**59**:118-125

[54] Goering W, Ribarska T, Schulz WA. Selective changes of retroelement expression in human prostate cancer. Carcinogenesis. 2011;**32**(10):1484-1492

[55] Sytnikova YA et al. Transposable element dynamics and PIWI regulation impacts lncRNA and gene expression diversity in Drosophila ovarian cell cultures. Genome Research. 2014;**24**(12):1977-1990

[56] Ozata DM et al. PIWI-interacting RNAs: Small RNAs with big functions. Nature Reviews. Genetics. 2019;**20**(2):89-108

[57] Lim AK, Tao L, Kai T. piRNAs mediate posttranscriptional retroelement silencing and localization to pi-bodies in the Drosophila germline. The Journal of Cell Biology. 2009;**186**(3):333-342

[58] Toth KF et al. The piRNA pathway guards the germline genome against transposable elements. Advances in Experimental Medicine and Biology. 2016;**886**:51-77

[59] Siomi MC et al. PIWI-interacting small RNAs: The vanguard of genome defence. Nature Reviews. Molecular Cell Biology. 2011;**12**(4):246-258

[60] Inoue K et al. Switching of dominant retrotransposon silencing strategies from posttranscriptional to transcriptional mechanisms during male germ-cell development in mice. PLoS Genetics. 2017;**13**(7):e1006926

[61] Cheng Y et al. Emerging roles of piRNAs in cancer: Challenges and prospects. Aging (Albany NY). 2019;**11**(21):9932-9946

[62] Yu Y, Xiao J, Hann SS. The emerging roles of PIWI-interacting RNA in human cancers. Cancer Management and Research. 2019;**11**:5895-5909

[63] Maleki Dana P, Mansournia MA, Mirhashemi SM. PIWI-interacting RNAs: New biomarkers for diagnosis and treatment of breast cancer. Cell & Bioscience. 2020;**10**:44

[64] Liu Y et al. The emerging role of the piRNA/piwi complex in cancer. Molecular Cancer. 2019;**18**(1):123

[65] Chen Z et al. Stem cell protein Piwil1 endowed endometrial cancer cells with stem-like properties via inducing epithelial-mesenchymal transition. BMC Cancer. 2015;**15**:811

[66] Qu X et al. PIWIL2 promotes progression of non-small cell lung cancer by inducing CDK2 and Cyclin A expression. Journal of Translational Medicine. 2015;**13**:301

[67] Jiang L et al. Downregulation of Piwil3 suppresses cell proliferation, migration and invasion in gastric cancer. Cancer Biomarkers. 2017;**20**(4):499-509

[68] Wang Z et al. The role of PIWIL4, an Argonaute family protein, in breast cancer. The Journal of Biological Chemistry. 2016;**291**(20):10646-10658

[69] Chiu YL, Greene WC. The APOBEC3 cytidine deaminases: An innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annual Review of Immunology. 2008;**26**:317-353

[70] Kinomoto M et al. All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Research. 2007;**35**(9):2955-2964

[71] Liang W et al. APOBEC3DE inhibits LINE-1 Retrotransposition by interacting with ORF1p and influencing LINE reverse transcriptase activity. PLoS One. 2016;**11**(7):e0157220

[72] Choi J, Hwang SY, Ahn K. Interplay between RNASEH2 and MOV10 controls LINE-1 retrotransposition. Nucleic Acids Research. 2018;**46**(4):1912-1926

[73] Hu S et al. SAMHD1 inhibits LINE-1 retrotransposition by promoting stress granule formation. PLoS Genetics. 2015;**11**(7):e1005367

[74] Goodier JL et al. The broadspectrum antiviral protein ZAP restricts human retrotransposition. PLoS Genetics. 2015;**11**(5):e1005252

[75] Kohnken R, Kodigepalli KM, Wu L. Regulation of deoxynucleotide metabolism in cancer: Novel mechanisms and therapeutic implications. Molecular Cancer. 2015;**14**:176

[76] Schneider AM et al. Roles of retrotransposons in benign and

**99**

*Endogenous Retroelements in Cancer: Molecular Roles and Clinical Approach*

[87] Lee E et al. Landscape of somatic retrotransposition in human cancers. Science. 2012;**337**(6097):967-971

mutagenesis of human genomes by endogenous retrotransposons. Cell.

[89] Miki Y et al. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer

retrotransposition is a common feature of mammalian hepatocarcinogenesis. Genome Research. 2018;**28**(5):639-653

[91] Nakagawa H, Fujita M. Whole genome sequencing analysis for cancer genomics and precision medicine. Cancer Science. 2018;**109**(3):513-522

[92] Hancks DC, Kazazian HH Jr. Roles for retrotransposon insertions in human

[93] Cakmak Guner B et al. Detection of HERV-K6 and HERV-K11 transpositions in the human genome. Biomedical

[94] Thayer RE, Singer MF, Fanning TG. Undermethylation of specific LINE-1 sequences in human cells producing a LINE-1-encoded protein. Gene.

[95] Baba Y et al. Long interspersed element-1 methylation level as a

[96] Piskareva O et al. The human L1 element: A potential biomarker in cancer prognosis, current status and future directions. Current Molecular

methyltransferases and their roles in tumorigenesis. Biomarker Research.

Medicine. 2011;**11**(4):286-303

[97] Zhang W, Xu J. DNA

2017;**5**:1

prognostic biomarker in gastrointestinal cancers. Digestion. 2018;**97**(1):26-30

disease. Mobile DNA. 2016;**7**:9

Reports. 2018;**9**(1):53-59

1993;**133**(2):273-277

[88] Iskow RC et al. Natural

Research. 1992;**52**(3):643-645

[90] Schauer SN et al. L1

2010;**141**(7):1253-1261

*DOI: http://dx.doi.org/10.5772/intechopen.93370*

malignant hematologic disease. Cell.

[77] Crichton J et al. Defending the genome from the enemy within: Mechanisms of retrotransposon suppression in the mouse germline. Cellular and Molecular Life Sciences.

2009;**6**(2):121-145

2014;**71**(9):1581-1605

2012;**46**:651-675

[78] Huang CR, Burns KH, Boeke JD. Active transposition in genomes. Annual Review of Genetics.

Genetics. 2007;**41**:331-368

Medicine. 2012;**4**(2):12

[82] Yi K, Ju YS. Patterns and

[79] Feschotte C, Pritham EJ. DNA transposons and the evolution of eukaryotic genomes. Annual Review of

[80] Belancio VP, Roy-Engel AM, Deininger PL. All y'all need to know 'bout retroelements in cancer. Seminars in Cancer Biology. 2010;**20**(4):200-210

[81] Solyom S, Kazazian HH Jr. Mobile elements in the human genome: Implications for disease. Genome

mechanisms of structural variations in human cancer. Experimental & Molecular Medicine. 2018;**50**(8):98

[83] Erwin JA et al. L1-associated genomic regions are deleted in somatic cells of the healthy human brain. Nature Neuroscience. 2016;**19**(12):1583-1591

[84] Scott EC, Devine SE. The role of somatic L1 retrotransposition in human

retrotransposition in human cancer revealed by whole-genome and exome sequencing. Genome Research.

cancers. Viruses. 2017;**9**(6):131

[86] Shukla R et al. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma.

[85] Helman E et al. Somatic

2014;**24**(7):1053-1063

Cell. 2013;**153**(1):101-111

*Endogenous Retroelements in Cancer: Molecular Roles and Clinical Approach DOI: http://dx.doi.org/10.5772/intechopen.93370*

malignant hematologic disease. Cell. 2009;**6**(2):121-145

*Methods in Molecular Medicine*

2009;**186**(3):333-342

2016;**886**:51-77

to pi-bodies in the Drosophila

germline. The Journal of Cell Biology.

[67] Jiang L et al. Downregulation of Piwil3 suppresses cell proliferation, migration and invasion in gastric cancer. Cancer Biomarkers.

[68] Wang Z et al. The role of PIWIL4, an Argonaute family protein, in breast cancer. The Journal of Biological Chemistry. 2016;**291**(20):10646-10658

[69] Chiu YL, Greene WC. The APOBEC3 cytidine deaminases: An innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annual Review of Immunology. 2008;**26**:317-353

[70] Kinomoto M et al. All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Research. 2007;**35**(9):2955-2964

[71] Liang W et al. APOBEC3DE inhibits LINE-1 Retrotransposition by interacting with ORF1p and influencing LINE reverse transcriptase activity. PLoS One. 2016;**11**(7):e0157220

[72] Choi J, Hwang SY, Ahn K. Interplay between RNASEH2 and MOV10 controls LINE-1 retrotransposition. Nucleic Acids Research. 2018;**46**(4):1912-1926

[73] Hu S et al. SAMHD1 inhibits LINE-1 retrotransposition by promoting stress granule formation. PLoS Genetics.

spectrum antiviral protein ZAP restricts

2015;**11**(7):e1005367

[74] Goodier JL et al. The broad-

human retrotransposition. PLoS Genetics. 2015;**11**(5):e1005252

[75] Kohnken R, Kodigepalli KM, Wu L. Regulation of deoxynucleotide

[76] Schneider AM et al. Roles of retrotransposons in benign and

metabolism in cancer: Novel mechanisms and therapeutic implications. Molecular Cancer.

2015;**14**:176

2017;**20**(4):499-509

[58] Toth KF et al. The piRNA pathway guards the germline genome against transposable elements. Advances in Experimental Medicine and Biology.

[59] Siomi MC et al. PIWI-interacting small RNAs: The vanguard of genome defence. Nature Reviews. Molecular Cell

Biology. 2011;**12**(4):246-258

[60] Inoue K et al. Switching of dominant retrotransposon silencing strategies from posttranscriptional to transcriptional mechanisms during male germ-cell development in mice. PLoS Genetics. 2017;**13**(7):e1006926

[61] Cheng Y et al. Emerging roles of piRNAs in cancer: Challenges and prospects. Aging (Albany NY).

[62] Yu Y, Xiao J, Hann SS. The emerging roles of PIWI-interacting RNA in human cancers. Cancer Management and Research. 2019;**11**:5895-5909

[63] Maleki Dana P, Mansournia MA, Mirhashemi SM. PIWI-interacting RNAs: New biomarkers for diagnosis and treatment of breast cancer. Cell &

[64] Liu Y et al. The emerging role of the piRNA/piwi complex in cancer. Molecular Cancer. 2019;**18**(1):123

[65] Chen Z et al. Stem cell protein Piwil1 endowed endometrial cancer cells with stem-like properties via inducing epithelial-mesenchymal transition.

[66] Qu X et al. PIWIL2 promotes progression of non-small cell lung cancer by inducing CDK2 and Cyclin A expression. Journal of Translational

2019;**11**(21):9932-9946

Bioscience. 2020;**10**:44

BMC Cancer. 2015;**15**:811

Medicine. 2015;**13**:301

**98**

[77] Crichton J et al. Defending the genome from the enemy within: Mechanisms of retrotransposon suppression in the mouse germline. Cellular and Molecular Life Sciences. 2014;**71**(9):1581-1605

[78] Huang CR, Burns KH, Boeke JD. Active transposition in genomes. Annual Review of Genetics. 2012;**46**:651-675

[79] Feschotte C, Pritham EJ. DNA transposons and the evolution of eukaryotic genomes. Annual Review of Genetics. 2007;**41**:331-368

[80] Belancio VP, Roy-Engel AM, Deininger PL. All y'all need to know 'bout retroelements in cancer. Seminars in Cancer Biology. 2010;**20**(4):200-210

[81] Solyom S, Kazazian HH Jr. Mobile elements in the human genome: Implications for disease. Genome Medicine. 2012;**4**(2):12

[82] Yi K, Ju YS. Patterns and mechanisms of structural variations in human cancer. Experimental & Molecular Medicine. 2018;**50**(8):98

[83] Erwin JA et al. L1-associated genomic regions are deleted in somatic cells of the healthy human brain. Nature Neuroscience. 2016;**19**(12):1583-1591

[84] Scott EC, Devine SE. The role of somatic L1 retrotransposition in human cancers. Viruses. 2017;**9**(6):131

[85] Helman E et al. Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing. Genome Research. 2014;**24**(7):1053-1063

[86] Shukla R et al. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell. 2013;**153**(1):101-111

[87] Lee E et al. Landscape of somatic retrotransposition in human cancers. Science. 2012;**337**(6097):967-971

[88] Iskow RC et al. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell. 2010;**141**(7):1253-1261

[89] Miki Y et al. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Research. 1992;**52**(3):643-645

[90] Schauer SN et al. L1 retrotransposition is a common feature of mammalian hepatocarcinogenesis. Genome Research. 2018;**28**(5):639-653

[91] Nakagawa H, Fujita M. Whole genome sequencing analysis for cancer genomics and precision medicine. Cancer Science. 2018;**109**(3):513-522

[92] Hancks DC, Kazazian HH Jr. Roles for retrotransposon insertions in human disease. Mobile DNA. 2016;**7**:9

[93] Cakmak Guner B et al. Detection of HERV-K6 and HERV-K11 transpositions in the human genome. Biomedical Reports. 2018;**9**(1):53-59

[94] Thayer RE, Singer MF, Fanning TG. Undermethylation of specific LINE-1 sequences in human cells producing a LINE-1-encoded protein. Gene. 1993;**133**(2):273-277

[95] Baba Y et al. Long interspersed element-1 methylation level as a prognostic biomarker in gastrointestinal cancers. Digestion. 2018;**97**(1):26-30

[96] Piskareva O et al. The human L1 element: A potential biomarker in cancer prognosis, current status and future directions. Current Molecular Medicine. 2011;**11**(4):286-303

[97] Zhang W, Xu J. DNA methyltransferases and their roles in tumorigenesis. Biomarker Research. 2017;**5**:1

[98] Gaudet F et al. Induction of tumors in mice by genomic hypomethylation. Science. 2003;**300**(5618):489-492

[99] Lamprecht B, Bonifer C, Mathas S. Repeat-element driven activation of proto-oncogenes in human malignancies. Cell Cycle. 2010;**9**(21):4276-4281

[100] Veeck J, Esteller M. Breast cancer epigenetics: From DNA methylation to microRNAs. Journal of Mammary Gland Biology and Neoplasia. 2010;**15**(1):5-17

[101] Chishima T, Iwakiri J, Hamada M. Identification of transposable elements contributing to tissue-specific expression of long non-coding RNAs. Genes (Basel). 2018;**9**(1):23

[102] Tufarelli C, Cruickshanks HA, Meehan RR. LINE-1 activation and epigenetic silencing of suppressor genes in cancer: Causally related events? Mobile Genetic Elements. 2013;**3**(5):e26832

[103] Kukurba KR, Montgomery SB. RNA sequencing and analysis. Cold Spring Harbor Protocols. 2015;**2015**(11):951-969

[104] Zhang X et al. Non-coding RNAs and retroviruses. Retrovirology. 2018;**15**(1):20

[105] Kapusta A et al. Transposable elements are major contributors to the origin, diversification, and regulation of vertebrate long noncoding RNAs. PLoS Genetics. 2013;**9**(4):e1003470

[106] Sparber P et al. The role of long non-coding RNAs in the pathogenesis of hereditary diseases. BMC Medical Genomics. 2019;**12**(Suppl 2):42

[107] Cartault F et al. Mutation in a primate-conserved retrotransposon reveals a noncoding RNA as a mediator of infantile encephalopathy. Proceedings of the National Academy of Sciences of the United States of America. 2012;**109**(13):4980-4985

[108] Hadjiargyrou M, Delihas N. The intertwining of transposable elements and non-coding RNAs. International Journal of Molecular Sciences. 2013;**14**(7):13307-13328

[109] Negishi M et al. A new lncRNA, APTR, associates with and represses the CDKN1A/p21 promoter by recruiting polycomb proteins. PLoS One. 2014;**9**(4):e95216

[110] Kelley D, Rinn J. Transposable elements reveal a stem cell-specific class of long noncoding RNAs. Genome Biology. 2012;**13**(11):R107

[111] Pan Y et al. The emerging roles of long noncoding RNA ROR (lincRNA-ROR) and its possible mechanisms in human cancers. Cellular Physiology and Biochemistry. 2016;**40**(1-2):219-229

[112] Wang G et al. Regulation of proto-oncogene transcription, cell proliferation, and tumorigenesis in mice by PSF protein and a VL30 noncoding RNA. Proceedings of the National Academy of Sciences of the United States of America. 2009;**106**(39):16794-16798

[113] Xu L et al. A novel function of RNAs arising from the long terminal repeat of human endogenous retrovirus 9 in cell cycle arrest. Journal of Virology. 2013;**87**(1):25-36

[114] Stetson DB et al. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell. 2008;**134**(4):587-598

[115] Yu Q et al. Type I interferon controls propagation of long interspersed element-1. The Journal of Biological Chemistry. 2015;**290**(16):10191-10199

[116] Ishak CA et al. An RB-EZH2 complex mediates silencing of repetitive

**101**

*Endogenous Retroelements in Cancer: Molecular Roles and Clinical Approach*

[126] Burns KH. Transposable elements in cancer. Nature Reviews. Cancer.

[127] Rodic N et al. Long interspersed element-1 protein expression is a hallmark of many human cancers. The American Journal of Pathology.

[128] Sur D et al. Detection of the LINE-1 retrotransposon RNA-binding protein ORF1p in different anatomical regions of the human brain. Mobile DNA.

[129] De Luca C et al. Enhanced expression of LINE-1-encoded ORF2 protein in early stages of colon and prostate transformation. Oncotarget.

[130] Grandi N, Tramontano E. HERV envelope proteins: Physiological role and pathogenic potential in cancer and autoimmunity. Frontiers in Microbiology. 2018;**9**:462

[131] Cegolon L et al. Human

BMC Cancer. 2013;**13**:4

2014;**15**(6):9173-9183

in Oncology. 2013;**3**:243

2014;**35**(6):1209-1216

endogenous retroviruses and cancer prevention: Evidence and prospects.

[132] Rhyu DW et al. Expression of human endogenous retrovirus env genes in the blood of breast cancer patients. International Journal of Molecular Sciences.

[133] Cherkasova E, Weisman Q, Childs RW. Endogenous retroviruses as targets for antitumor immunity in renal cell cancer and other tumors. Frontiers

[134] Xue B, He L. An expanding universe of the non-coding genome in cancer biology. Carcinogenesis.

[135] Chan SM et al. The HERV-K accessory protein Np9 controls viability

2016;**7**(4):4048-4061

2017;**17**(7):415-424

2014;**184**(5):1280-1286

2017;**8**:17

*DOI: http://dx.doi.org/10.5772/intechopen.93370*

DNA sequences. Molecular Cell.

[117] Gasche JA et al. Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. International Journal of Cancer.

[118] Finnegan DJ. Retrotransposons. Current Biology. 2012;**22**(11):R432-R437

transcriptome analysis of retroelements

*migratoria*. PLoS One. 2012;**7**(7):e40532

[119] Jiang F et al. Large-scale

in the migratory locust, *Locusta* 

[120] Martin SL. The ORF1 protein encoded by LINE-1: Structure and function during L1 retrotransposition.

Biotechnology. 2006;**2006**(1):45621

[121] Garcia-Montojo M et al. Human endogenous retrovirus-K (HML-2): A comprehensive review. Critical Reviews in Microbiology. 2018;**44**(6):715-738

[122] Li F, Karlsson H. Expression and regulation of human endogenous retrovirus W elements. APMIS.

[123] Soygur B, Sati L. The role of syncytins in human reproduction and reproductive organ cancers. Reproduction. 2016;**152**(5):R167-R178

[124] Gimenez J et al. Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control. Nucleic Acids Research.

Journal of Biomedicine &

2016;**124**(1-2):52-66

2010;**38**(7):2229-2246

2007;**85**(1):23-38

[125] Strick R et al. Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral Syncytin-1 and regulated by TGF-beta. Journal of Molecular Medicine (Berlin, Germany).

2016;**64**(6):1074-1087

2011;**129**(5):1053-1063

*Endogenous Retroelements in Cancer: Molecular Roles and Clinical Approach DOI: http://dx.doi.org/10.5772/intechopen.93370*

DNA sequences. Molecular Cell. 2016;**64**(6):1074-1087

*Methods in Molecular Medicine*

[99] Lamprecht B, Bonifer C, Mathas S. Repeat-element driven activation of proto-oncogenes in human malignancies. Cell Cycle.

2010;**9**(21):4276-4281

[98] Gaudet F et al. Induction of tumors in mice by genomic hypomethylation. Science. 2003;**300**(5618):489-492

of Sciences of the United States of America. 2012;**109**(13):4980-4985

[108] Hadjiargyrou M, Delihas N. The intertwining of transposable elements and non-coding RNAs. International Journal of Molecular Sciences. 2013;**14**(7):13307-13328

[109] Negishi M et al. A new lncRNA, APTR, associates with and represses the CDKN1A/p21 promoter by recruiting polycomb proteins. PLoS One.

[110] Kelley D, Rinn J. Transposable elements reveal a stem cell-specific class of long noncoding RNAs. Genome

[111] Pan Y et al. The emerging roles of long noncoding RNA ROR (lincRNA-ROR) and its possible mechanisms in human cancers. Cellular Physiology and Biochemistry. 2016;**40**(1-2):219-229

[112] Wang G et al. Regulation of proto-oncogene transcription, cell proliferation, and tumorigenesis in mice by PSF protein and a VL30 noncoding RNA. Proceedings of the National Academy of Sciences of the United States of America. 2009;**106**(39):16794-16798

[113] Xu L et al. A novel function of RNAs arising from the long terminal repeat of human endogenous retrovirus 9 in cell cycle arrest. Journal of Virology.

[114] Stetson DB et al. Trex1 prevents cell-intrinsic initiation of autoimmunity.

[115] Yu Q et al. Type I interferon controls propagation of long interspersed element-1. The Journal of Biological Chemistry. 2015;**290**(16):10191-10199

[116] Ishak CA et al. An RB-EZH2 complex mediates silencing of repetitive

Cell. 2008;**134**(4):587-598

2013;**87**(1):25-36

Biology. 2012;**13**(11):R107

2014;**9**(4):e95216

[100] Veeck J, Esteller M. Breast cancer epigenetics: From DNA methylation to microRNAs. Journal of Mammary Gland Biology and Neoplasia. 2010;**15**(1):5-17

[101] Chishima T, Iwakiri J, Hamada M. Identification of transposable elements

expression of long non-coding RNAs.

[102] Tufarelli C, Cruickshanks HA, Meehan RR. LINE-1 activation and epigenetic silencing of suppressor genes in cancer: Causally related events? Mobile Genetic Elements.

[103] Kukurba KR, Montgomery SB. RNA sequencing and analysis. Cold Spring Harbor Protocols.

[104] Zhang X et al. Non-coding RNAs and retroviruses. Retrovirology.

[105] Kapusta A et al. Transposable elements are major contributors to the origin, diversification, and regulation of vertebrate long noncoding RNAs. PLoS

[106] Sparber P et al. The role of long non-coding RNAs in the pathogenesis of hereditary diseases. BMC Medical Genomics. 2019;**12**(Suppl 2):42

[107] Cartault F et al. Mutation in a primate-conserved retrotransposon reveals a noncoding RNA as a

mediator of infantile encephalopathy. Proceedings of the National Academy

Genetics. 2013;**9**(4):e1003470

contributing to tissue-specific

Genes (Basel). 2018;**9**(1):23

2013;**3**(5):e26832

2018;**15**(1):20

2015;**2015**(11):951-969

**100**

[117] Gasche JA et al. Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. International Journal of Cancer. 2011;**129**(5):1053-1063

[118] Finnegan DJ. Retrotransposons. Current Biology. 2012;**22**(11):R432-R437

[119] Jiang F et al. Large-scale transcriptome analysis of retroelements in the migratory locust, *Locusta migratoria*. PLoS One. 2012;**7**(7):e40532

[120] Martin SL. The ORF1 protein encoded by LINE-1: Structure and function during L1 retrotransposition. Journal of Biomedicine & Biotechnology. 2006;**2006**(1):45621

[121] Garcia-Montojo M et al. Human endogenous retrovirus-K (HML-2): A comprehensive review. Critical Reviews in Microbiology. 2018;**44**(6):715-738

[122] Li F, Karlsson H. Expression and regulation of human endogenous retrovirus W elements. APMIS. 2016;**124**(1-2):52-66

[123] Soygur B, Sati L. The role of syncytins in human reproduction and reproductive organ cancers. Reproduction. 2016;**152**(5):R167-R178

[124] Gimenez J et al. Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control. Nucleic Acids Research. 2010;**38**(7):2229-2246

[125] Strick R et al. Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral Syncytin-1 and regulated by TGF-beta. Journal of Molecular Medicine (Berlin, Germany). 2007;**85**(1):23-38

[126] Burns KH. Transposable elements in cancer. Nature Reviews. Cancer. 2017;**17**(7):415-424

[127] Rodic N et al. Long interspersed element-1 protein expression is a hallmark of many human cancers. The American Journal of Pathology. 2014;**184**(5):1280-1286

[128] Sur D et al. Detection of the LINE-1 retrotransposon RNA-binding protein ORF1p in different anatomical regions of the human brain. Mobile DNA. 2017;**8**:17

[129] De Luca C et al. Enhanced expression of LINE-1-encoded ORF2 protein in early stages of colon and prostate transformation. Oncotarget. 2016;**7**(4):4048-4061

[130] Grandi N, Tramontano E. HERV envelope proteins: Physiological role and pathogenic potential in cancer and autoimmunity. Frontiers in Microbiology. 2018;**9**:462

[131] Cegolon L et al. Human endogenous retroviruses and cancer prevention: Evidence and prospects. BMC Cancer. 2013;**13**:4

[132] Rhyu DW et al. Expression of human endogenous retrovirus env genes in the blood of breast cancer patients. International Journal of Molecular Sciences. 2014;**15**(6):9173-9183

[133] Cherkasova E, Weisman Q, Childs RW. Endogenous retroviruses as targets for antitumor immunity in renal cell cancer and other tumors. Frontiers in Oncology. 2013;**3**:243

[134] Xue B, He L. An expanding universe of the non-coding genome in cancer biology. Carcinogenesis. 2014;**35**(6):1209-1216

[135] Chan SM et al. The HERV-K accessory protein Np9 controls viability and migration of teratocarcinoma cells. PLoS One. 2019;**14**(2):e0212970

[136] Denne M et al. Physical and functional interactions of human endogenous retrovirus proteins Np9 and rec with the promyelocytic leukemia zinc finger protein. Journal of Virology. 2007;**81**(11):5607-5616

[137] Baeissa H et al. Identification and analysis of mutational hotspots in oncogenes and tumour suppressors. Oncotarget. 2017;**8**(13):21290-21304

[138] Steranka JP et al. Transposon insertion profiling by sequencing (TIPseq) for mapping LINE-1 insertions in the human genome. Mobile DNA. 2019;**10**:8

[139] Ewing AD. Transposable element detection from whole genome sequence data. Mobile DNA. 2015;**6**:24

[140] Jung H, Choi JK, Lee EA. Immune signatures correlate with L1 retrotransposition in gastrointestinal cancers. Genome Research. 2018;**28**(8):1136-1146

[141] Chang TC et al. Investigation of somatic single nucleotide variations in human endogenous retrovirus elements and their potential association with cancer. PLoS One. 2019;**14**(4):e0213770

[142] Ehrlich M. DNA methylation in cancer: Too much, but also too little. Oncogene. 2002;**21**(35):5400-5413

[143] Kitkumthorn N, Mutirangura A. Long interspersed nuclear element-1 hypomethylation in cancer: Biology and clinical applications. Clinical Epigenetics. 2011;**2**:315-330

[144] Locke WJ et al. DNA methylation cancer biomarkers: Translation to the clinic. Frontiers in Genetics. 2019;**10**:1150

[145] Miyata T et al. Prognostic value of LINE-1 methylation level in 321

patients with primary liver cancer including hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Oncotarget. 2018;**9**(29):20795-20806

[146] Saito K et al. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer. Clinical Cancer Research. 2010;**16**(8):2418-2426

[147] Barchitta M et al. LINE-1 hypomethylation in blood and tissue samples as an epigenetic marker for cancer risk: A systematic review and meta-analysis. PLoS One. 2014;**9**(10):e109478

[148] Bakshi A et al. DNA methylation variation of human-specific Alu repeats. Epigenetics. 2016;**11**(2):163-173

[149] Leontiou CA et al. Bisulfite conversion of DNA: Performance comparison of different kits and methylation quantitation of epigenetic biomarkers that have the potential to be used in non-invasive prenatal testing. PLoS One. 2015;**10**(8):e0135058

[150] Kurdyukov S, Bullock M. DNA methylation analysis: Choosing the right method. Biology (Basel). 2016;**5**(1):3

[151] Shim J et al. Detection and quantification of methylation in DNA using solid-state Nanopores. Scientific Reports. 2013;**3**:1389

[152] Gonzalgo ML, Liang G. Methylation-sensitive single-nucleotide primer extension (Ms-SNuPE) for quantitative measurement of DNA methylation. Nature Protocols. 2007;**2**(8):1931-1936

[153] Irahara N et al. Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells. The Journal of Molecular Diagnostics. 2010;**12**(2):177-183

**103**

*Endogenous Retroelements in Cancer: Molecular Roles and Clinical Approach*

[163] Ardeljan D et al. The human long interspersed element-1 retrotransposon: An emerging biomarker of neoplasia. Clinical Chemistry. 2017;**63**(4):816-822

[164] Chen L et al. Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer. Breast Cancer Research and Treatment. 2012;**136**(1):129-142

[165] Anwar SL, Wulaningsih W, Lehmann U. Transposable elements in human cancer: Causes and consequences of deregulation. International Journal of Molecular Sciences. 2017;**18**(5):974

[166] Sciamanna I et al. Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. Oncogene. 2005;**24**(24):3923-3931

[167] Carlini F et al. The reverse

transcription inhibitor Abacavir shows anticancer activity in prostate cancer cell lines. PLoS One. 2010;**5**(12):e14221

[168] Hecht M et al. Efavirenz has the highest anti-proliferative effect of non-nucleoside reverse transcriptase inhibitors against pancreatic cancer cells. PLoS One. 2015;**10**(6):e0130277

[169] Oricchio E et al. Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression. Oncogene.

Spadafora C. The reverse transcriptase encoded by LINE-1 retrotransposons in the genesis, progression, and therapy of cancer. Frontiers in Chemistry. 2016;**4**:6

[171] Houede N et al. A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castrationresistant prostate cancer. The Oncologist. 2014;**19**(12):1227-1228

[172] Sciamanna I et al. LINE-1-encoded reverse transcriptase as a target in

2007;**26**(29):4226-4233

[170] Sciamanna I, De Luca C,

*DOI: http://dx.doi.org/10.5772/intechopen.93370*

[154] Lee KH et al. Methylation of LINE-1 in cell-free DNA serves as a liquid biopsy biomarker for human breast cancers and dog mammary tumors. Scientific Reports.

[155] Salvi S et al. Cell-free DNA as a diagnostic marker for cancer: Current insights. Oncotargets and Therapy.

[156] Martinez VG et al. Epigenetics of bladder cancer: Where biomarkers and therapeutic targets meet. Frontiers in

[157] Zare M et al. Human endogenous retrovirus env genes: Potential blood biomarkers in lung cancer. Microbial Pathogenesis. 2018;**115**:189-193

[158] Ma WJ et al. Human endogenous retroviruses-K (HML-2) expression is correlated with prognosis and progress of hepatocellular carcinoma. BioMed Research International.

[159] Janakiram M et al. Expression, clinical significance, and receptor identification of the newest B7 family member HHLA2 protein. Clinical Cancer Research. 2015;**21**(10):2359-2366

[160] Wang-Johanning F et al. Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer. International Journal of Cancer. 2014;**134**(3):587-595

[161] Downey RF et al. Human endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice? International Journal of Cancer. 2015;**137**(6):1249-1257

[162] Buscher K et al. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Research. 2005;**65**(10):4172-4180

2019;**9**(1):175

2016;**9**:6549-6559

Genetics. 2019;**10**

2016;**2016**:8201642

*Endogenous Retroelements in Cancer: Molecular Roles and Clinical Approach DOI: http://dx.doi.org/10.5772/intechopen.93370*

[154] Lee KH et al. Methylation of LINE-1 in cell-free DNA serves as a liquid biopsy biomarker for human breast cancers and dog mammary tumors. Scientific Reports. 2019;**9**(1):175

*Methods in Molecular Medicine*

2007;**81**(11):5607-5616

2019;**10**:8

and migration of teratocarcinoma cells.

patients with primary liver cancer including hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Oncotarget. 2018;**9**(29):20795-20806

[146] Saito K et al. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer. Clinical Cancer Research. 2010;**16**(8):2418-2426

[147] Barchitta M et al. LINE-1 hypomethylation in blood and tissue samples as an epigenetic marker for cancer risk: A systematic review and meta-analysis. PLoS One.

[148] Bakshi A et al. DNA methylation variation of human-specific Alu repeats.

Epigenetics. 2016;**11**(2):163-173

[149] Leontiou CA et al. Bisulfite conversion of DNA: Performance comparison of different kits and methylation quantitation of epigenetic biomarkers that have the potential to be used in non-invasive prenatal testing. PLoS One. 2015;**10**(8):e0135058

[150] Kurdyukov S, Bullock M. DNA methylation analysis: Choosing the right method. Biology (Basel). 2016;**5**(1):3

[151] Shim J et al. Detection and quantification of methylation in DNA using solid-state Nanopores. Scientific

[152] Gonzalgo ML, Liang G.

[153] Irahara N et al. Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells. The Journal of Molecular Diagnostics. 2010;**12**(2):177-183

Methylation-sensitive single-nucleotide primer extension (Ms-SNuPE) for quantitative measurement of DNA methylation. Nature Protocols.

Reports. 2013;**3**:1389

2007;**2**(8):1931-1936

2014;**9**(10):e109478

PLoS One. 2019;**14**(2):e0212970

[136] Denne M et al. Physical and functional interactions of human endogenous retrovirus proteins Np9 and rec with the promyelocytic leukemia zinc finger protein. Journal of Virology.

[137] Baeissa H et al. Identification and analysis of mutational hotspots in oncogenes and tumour suppressors. Oncotarget. 2017;**8**(13):21290-21304

[138] Steranka JP et al. Transposon insertion profiling by sequencing (TIPseq) for mapping LINE-1 insertions in the human genome. Mobile DNA.

[139] Ewing AD. Transposable element detection from whole genome sequence

data. Mobile DNA. 2015;**6**:24

[140] Jung H, Choi JK, Lee EA. Immune signatures correlate with L1 retrotransposition in gastrointestinal

cancers. Genome Research. 2018;**28**(8):1136-1146

[141] Chang TC et al. Investigation of somatic single nucleotide variations in human endogenous retrovirus elements and their potential association with cancer. PLoS One. 2019;**14**(4):e0213770

[142] Ehrlich M. DNA methylation in cancer: Too much, but also too little. Oncogene. 2002;**21**(35):5400-5413

[143] Kitkumthorn N, Mutirangura A. Long interspersed nuclear element-1 hypomethylation in cancer: Biology and clinical applications. Clinical Epigenetics. 2011;**2**:315-330

[144] Locke WJ et al. DNA methylation cancer biomarkers: Translation to the clinic. Frontiers in Genetics.

[145] Miyata T et al. Prognostic value of LINE-1 methylation level in 321

**102**

2019;**10**:1150

[155] Salvi S et al. Cell-free DNA as a diagnostic marker for cancer: Current insights. Oncotargets and Therapy. 2016;**9**:6549-6559

[156] Martinez VG et al. Epigenetics of bladder cancer: Where biomarkers and therapeutic targets meet. Frontiers in Genetics. 2019;**10**

[157] Zare M et al. Human endogenous retrovirus env genes: Potential blood biomarkers in lung cancer. Microbial Pathogenesis. 2018;**115**:189-193

[158] Ma WJ et al. Human endogenous retroviruses-K (HML-2) expression is correlated with prognosis and progress of hepatocellular carcinoma. BioMed Research International. 2016;**2016**:8201642

[159] Janakiram M et al. Expression, clinical significance, and receptor identification of the newest B7 family member HHLA2 protein. Clinical Cancer Research. 2015;**21**(10):2359-2366

[160] Wang-Johanning F et al. Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer. International Journal of Cancer. 2014;**134**(3):587-595

[161] Downey RF et al. Human endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice? International Journal of Cancer. 2015;**137**(6):1249-1257

[162] Buscher K et al. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Research. 2005;**65**(10):4172-4180

[163] Ardeljan D et al. The human long interspersed element-1 retrotransposon: An emerging biomarker of neoplasia. Clinical Chemistry. 2017;**63**(4):816-822

[164] Chen L et al. Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer. Breast Cancer Research and Treatment. 2012;**136**(1):129-142

[165] Anwar SL, Wulaningsih W, Lehmann U. Transposable elements in human cancer: Causes and consequences of deregulation. International Journal of Molecular Sciences. 2017;**18**(5):974

[166] Sciamanna I et al. Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. Oncogene. 2005;**24**(24):3923-3931

[167] Carlini F et al. The reverse transcription inhibitor Abacavir shows anticancer activity in prostate cancer cell lines. PLoS One. 2010;**5**(12):e14221

[168] Hecht M et al. Efavirenz has the highest anti-proliferative effect of non-nucleoside reverse transcriptase inhibitors against pancreatic cancer cells. PLoS One. 2015;**10**(6):e0130277

[169] Oricchio E et al. Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression. Oncogene. 2007;**26**(29):4226-4233

[170] Sciamanna I, De Luca C, Spadafora C. The reverse transcriptase encoded by LINE-1 retrotransposons in the genesis, progression, and therapy of cancer. Frontiers in Chemistry. 2016;**4**:6

[171] Houede N et al. A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castrationresistant prostate cancer. The Oncologist. 2014;**19**(12):1227-1228

[172] Sciamanna I et al. LINE-1-encoded reverse transcriptase as a target in

cancer therapy. Frontiers in Bioscience-Landmark. 2018;**23**:1360-1369

[173] Wang-Johanning F et al. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors. Journal of the National Cancer Institute. 2012;**104**(3):189-210

[174] Hodges-Vazquez M et al. The yellow fever 17D vaccine and risk of malignant melanoma in the United States military. Vaccine. 2012;**30**(30):4476-4479

[175] Mastrangelo G et al. Does yellow fever 17D vaccine protect against melanoma? Vaccine. 2009;**27**(4):588-591

[176] Mullins CS, Linnebacher M. Endogenous retrovirus sequences as a novel class of tumor-specific antigens: An example of HERV-H env encoding strong CTL epitopes. Cancer Immunology, Immunotherapy. 2012;**61**(7):1093-1100

[177] Kong Y et al. Transposable element expression in tumors is associated with immune infiltration and increased antigenicity. Nature Communications. 2019;**10**:5228

[178] Grandi N, Tramontano E. Human endogenous retroviruses are ancient acquired elements still shaping innate immune responses. Frontiers in Immunology. 2018;**9**:2039

[179] Roulois D et al. DNAdemethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts. Cell. 2015;**162**(5):961-973

**105**

Section 3

Genetics and Genomics in

Clinical Practice
